BMJ 2003;327:1177-1178 (22 November), doi:10.1136/bmj.327.7425.1177
Editorial
Controlling methicillin resistant Staphylococcus aureus
Time to return to more stringent methods of control in the United Kingdom?
| The first 150 words of the full text of this article appear below. |
Methicillin resistant Staphylococcus aureus (MRSA) is a major cause of hospital acquired infection worldwide, posing a growing threat to public health. It belongs to a species of ubiquitous and versatile organisms that are continually adapting to new antimicrobial and environmental challenges, often through gene transfers even from distantly related organisms such as vertebrates. Why is MRSA important? Some strains are eminently transmissible, resulting in large numbers of infections in hospitals. Bacteraemia data for England and Wales show that MRSA as a proportion of total Staphylococcus aureus bacteraemias rose from under 2% in 1990 to 42% in 20001
2one of the highest reported rates in Europe.
Methicillin resistance was first reported in 1961 shortly after the introduction of methicillin (similar to flucloxacillin), the first penicillin resistant to destruction by staphylococcal
-lactamase. The discovery of methicillin was an important development as many hospital strains of S aureus had become penicillin resistant in . . . [Full text of this article]
Division of Healthcare Associated Infection and Antimicrobial Resistance, Communicable Disease Surveillance Centre, Health Protection Agency, London NW9 5EQ (georgia.duckworth@hpa.org.uk)

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Relevant Article
-
Recent developments in
lactamases and extended spectrum
lactamases
- Joumana N Samaha-Kfoury and George F Araj
BMJ 2003 327: 1209-1213.
[Extract]
[Full Text]
[PDF]
This article has been cited by other articles:
-
Fang, C.-T., Shau, W.-Y., Hsueh, P.-R., Chen, Y.-C., Wang, J.-T., Hung, C.-C., Huang, L. Y. L., Chang, S.-C.
(2006). Early empirical glycopeptide therapy for patients with methicillin-resistant Staphylococcus aureus bacteraemia: impact on the outcome. J Antimicrob Chemother
57: 511-519
[Abstract]
[Full text]
-
Varughese, G. I, Miltsios, K., Buch, H. N, Orendi, J. M, Scarpello, J. H.
(2006). Mortality rates in hospital patients with hyperglycaemia and MRSA bacteraemia. British Journal of Diabetes & Vascular Disease
6: 42-44
[Abstract]
-
Dand, P., Fyvie, J., Yee, A., Sykes, N.
(2005). A survey of methicillin-resistant Staphylococcus aureus (MRSA) management in hospices/palliative care units. Palliat Med
19: 185-187
[Abstract]
-
Ali, S., Sykes, N., Flock, P., Hall, E., Buchan, J.
(2005). An investigation of MRSA infection in a hospice. Palliat Med
19: 188-196
[Abstract]
-
Newsom, S W B
(2004). MRSA--past, present, future. JRSM
97: 509-510
[Full text]
-
Newsom, S.W.B.
(2004). MRSA and its predecessor a historical view: Part three: the rise of MRSA and EMRSA. British Journal of Infection Control
5: 25-28
-
Turner, J. M, Hakeem, L. M, Lockman, K A., Bhattacharyya, D. N, Campbell, I. W
(2004). Diabetic MRSA foot infection -- role of linezolid therapy. British Journal of Diabetes & Vascular Disease
4: 44-46
[Abstract]
Rapid Responses:
Read all Rapid Responses
- Controlling methicillin resistant Staphylococcus aureus
- Alan W Fowler
bmj.com, 24 Nov 2003
[Full text]
- Ideal content for National electronic Library of Infection (NeLI)
- Jane Mani-Saada
bmj.com, 24 Nov 2003
[Full text]
- MRSA: it can be controlled
- Andrew N Bamji
bmj.com, 24 Nov 2003
[Full text]
- Controlling methicillin resistant Staphylococcus aureus in Cystic Fibrosis.
- Filippo Festini, et al.
bmj.com, 30 Nov 2003
[Full text]
- Prevention is better than cure
- Feroz Dinah
bmj.com, 3 Dec 2003
[Full text]
- Staphylococcus aureus infection not MRSA colonisation should be the focus of our efforts
- John Paul, et al.
bmj.com, 4 Dec 2003
[Full text]
- MRSA- answers are here.
- Eugene Sherry, et al.
bmj.com, 9 Dec 2003
[Full text]
- MRSA Education: Regional Perioperative Guidelines for Surgical Specialities
- Nadim Aslam
bmj.com, 12 Dec 2003
[Full text]
- Epidemiology of MRSA - frightening facts or dangerous fiction?
- Peter Wilson, et al.
bmj.com, 17 Feb 2004
[Full text]
- Methicillin Resistant Staphylococcus Aureus
- Peter M. Bretland
bmj.com, 10 Mar 2005
[Full text]